Tempest Therapeutics, Inc. is holding another meeting for stockholders to vote on a company rule change.

Oct 20, 2026, 4:13 PM ETPaperworkRead the original at SEC EDGAR

Neutral

Tempest Therapeutics' shareholder-rule proposal remains undecided after it lacked enough votes at the meeting. The vote was postponed, and the filing reports no change to company operations.

TPST · Tempest Therapeutics, Inc.

AI read · Neutral

The AI's read

The proposal concerns how stockholders can approve company matters, not a reported change to the company's work or products. More time to vote leaves the result open, so this filing alone does not change the company's business outlook.

Get alerts for TPST

Follow Tempest Therapeutics, Inc. (TPST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TPST

Free on the App Store and Google Play, or on the web.